Department of Molecular Genetics and Microbiology, Center for NeuroGenetics and the Genetics Institute, University of Florida, College of Medicine, Gainesville, FL 32610, USA.
Department of Neurology, University of Rochester, Rochester, NY 14642, USA.
Brain. 2023 Oct 3;146(10):4217-4232. doi: 10.1093/brain/awad148.
Myotonic dystrophy type 1 is a dominantly inherited multisystemic disease caused by CTG tandem repeat expansions in the DMPK 3' untranslated region. These expanded repeats are transcribed and produce toxic CUG RNAs that sequester and inhibit activities of the MBNL family of developmental RNA processing factors. Although myotonic dystrophy is classified as a muscular dystrophy, the brain is also severely affected by an unusual cohort of symptoms, including hypersomnia, executive dysfunction, as well as early onsets of tau/MAPT pathology and cerebral atrophy. To address the molecular and cellular events that lead to these pathological outcomes, we recently generated a mouse Dmpk CTG expansion knock-in model and identified choroid plexus epithelial cells as particularly affected by the expression of toxic CUG expansion RNAs. To determine if toxic CUG RNAs perturb choroid plexus functions, alternative splicing analysis was performed on lateral and hindbrain choroid plexi from Dmpk CTG knock-in mice. Choroid plexus transcriptome-wide changes were evaluated in Mbnl2 knockout mice, a developmental-onset model of myotonic dystrophy brain dysfunction. To determine if transcriptome changes also occurred in the human disease, we obtained post-mortem choroid plexus for RNA-seq from neurologically unaffected (two females, three males; ages 50-70 years) and myotonic dystrophy type 1 (one female, three males; ages 50-70 years) donors. To test that choroid plexus transcriptome alterations resulted in altered CSF composition, we obtained CSF via lumbar puncture from patients with myotonic dystrophy type 1 (five females, five males; ages 35-55 years) and non-myotonic dystrophy patients (three females, four males; ages 26-51 years), and western blot and osmolarity analyses were used to test CSF alterations predicted by choroid plexus transcriptome analysis. We determined that CUG RNA induced toxicity was more robust in the lateral choroid plexus of Dmpk CTG knock-in mice due to comparatively higher Dmpk and lower Mbnl RNA levels. Impaired transitions to adult splicing patterns during choroid plexus development were identified in Mbnl2 knockout mice, including mis-splicing previously found in Dmpk CTG knock-in mice. Whole transcriptome analysis of myotonic dystrophy type 1 choroid plexus revealed disease-associated RNA expression and mis-splicing events. Based on these RNA changes, predicted alterations in ion homeostasis, secretory output and CSF composition were confirmed by analysis of myotonic dystrophy type 1 CSF. Our results implicate choroid plexus spliceopathy and concomitant alterations in CSF homeostasis as an unappreciated contributor to myotonic dystrophy type 1 CNS pathogenesis.
1 型肌强直性营养不良是一种显性遗传的多系统疾病,由 DMPK3'非翻译区的 CTG 串联重复扩展引起。这些扩展的重复序列被转录,并产生毒性的 CUG RNA,这些 RNA 会隔离并抑制 MBNL 家族发育性 RNA 加工因子的活性。尽管肌强直性营养不良被归类为肌肉疾病,但大脑也受到一系列不寻常症状的严重影响,包括嗜睡、执行功能障碍,以及tau/MAPT 病理学和脑萎缩的早期发作。为了研究导致这些病理结果的分子和细胞事件,我们最近生成了一种 Dmpk CTG 扩展敲入模型的小鼠,并发现脉络丛上皮细胞特别受到毒性 CUG 扩展 RNA 的表达影响。为了确定毒性 CUG RNA 是否扰乱脉络丛功能,我们对 Dmpk CTG 敲入小鼠的侧脑室和后脑脉络丛进行了可变剪接分析。我们还在 Mbnl2 敲除小鼠中评估了脉络丛转录组的变化,Mbnl2 敲除小鼠是一种肌强直性营养不良脑功能障碍的发育性发病模型。为了确定人类疾病是否也发生了转录组变化,我们从神经功能正常的(两名女性,三名男性;年龄 50-70 岁)和 1 型肌强直性营养不良(一名女性,三名男性;年龄 50-70 岁)供体中获得了死后脉络丛用于 RNA-seq。为了测试脉络丛转录组改变是否导致脑脊液成分改变,我们从 1 型肌强直性营养不良患者(五名女性,五名男性;年龄 35-55 岁)和非肌强直性营养不良患者(三名女性,四名男性;年龄 26-51 岁)中通过腰椎穿刺获得了脑脊液,并使用 Western blot 和渗透压分析来测试脉络丛转录组分析预测的 CSF 改变。我们发现,由于 Dmpk 和 Mbnl RNA 水平相对较高,Dmpk CTG 敲入小鼠的侧脑室脉络丛中 CUG RNA 诱导的毒性更为明显。在 Mbnl2 敲除小鼠中发现了脉络丛发育过程中向成人剪接模式的转变受损,包括以前在 Dmpk CTG 敲入小鼠中发现的剪接错误。对 1 型肌强直性营养不良脉络丛的全转录组分析揭示了与疾病相关的 RNA 表达和剪接事件。基于这些 RNA 变化,通过对 1 型肌强直性营养不良患者脑脊液的分析,确认了离子稳态、分泌输出和 CSF 成分预测的改变。我们的研究结果表明,脉络丛剪接病和随之而来的 CSF 稳态改变是 1 型肌强直性营养不良中枢神经系统发病机制的一个未被认识的因素。